Succinyl-CoA synthetase (SCS) catalyzes the reversible interchange of purin
e nucleoside diphosphate, succinyl-CoA, and P-i with purine nucleoside trip
hosphate. succinate, and CoA via a phosphorylated histidine (H246 alpha) in
termediate. Two potential nucleotide-binding sites were predicted in the be
ta-subunit, and have been differentiated by photoaffinity labeling with 8-N
-3-ATP and by site-directed mutagenesis. It was demonstrated that 8-N-3-ATP
is a suitable analogue for probing the nucleotide-binding site of SCS. Two
tryptic peptides from the N-terminal domain of the beta-subunit were label
ed with 8-N-3-ATP. These corresponded to residues 107-119 beta and 121-146
beta, two regions lying along one side of an ATP-grasp Fold. A mutant prote
in with changes on the opposite side of the fold (G53 beta V/R53 beta E) wa
s unable to be phosphorylated using ATP or GTP, but could be phosphorylated
by succinyl-CoA and P-i. A mutant protein designed to probe nucleotide spe
cificity (P20 beta Q) had a K-m(app) for GTP that was more than 5 times low
er than that of wild-type SCS, whereas parameters for the other substrates
remained unchanged. Mutations of residues in the C-terminal domain of the b
eta-subunit designed to distrupt one loop of the Rossmann fold (I322 beta A
, and R324 beta N/D326 beta A) had the greatest effect on the binding of su
ccinate and CoA. They did not disrupt the phosphorylation of SCS with nucle
otides. It was concluded that the nucleotide-binding site is located in the
N-terminal domain of the beta-subunit. This implies that there are two act
ive sites similar to 35 Angstrom apart, and that the H246 alpha loop moves
between them during catalysis.